JLABS Korea, The Next Evolution Of J&J’s Innovation Model

Korea Seen As Emerging Hub For Biotech, Medtech R&D

In this video interview, Sharon Chan, vice-president, Johnson & Johnson Innovation – JLABS Asia Pacific, shares her views on what South Korea’s strengths are as a biotech and medtech R&D hub, JLABS's plans in the country and what role it wants for its local activities domestically and beyond.

korea
J&J sees JLABS Korea as demonstrating its commitment to APAC • Source: Shutterstock

The life science industry is one of the fastest-developing sectors in the Asia Pacific region, with many biopharma start-ups eager to transform the landscape of healthcare by delivering innovative solutions.

However, many of these young healthcare companies continue to be faced with business, financial and operational challenges as they try...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from South Korea

More from Focus On Asia